GlassScriptPhysician profile
Michael David Calfee
NPI 1568518736
$4,412.82
in general payments reported to CMS, 2019-2025
15 companies · $2,510 in 2025
The $2,510 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.50 · 2020: $51.22 · 2021: $1,474 · 2022: $46.16 · 2023: $57.32 · 2024: $177 · 2025: $2,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,572 · Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,572.10 |
| Food and Beverage | $1,171.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,474.17 | 2021 | |
| Smoky Mountain Surgical LLC | $1,086.15 | 2025 | |
| Arthrex, INC. | $616.40 | 2025 | |
| Stryker Corporation | $430.40 | 2025 | Makoplasty, Infinity Adaptis, Inbone |
| Medacta USA, INC. | $216.40 | 2025 | Amistem |
| Smith+Nephew, INC. | $152.73 | 2024 | Real Intelligence, Journey II, Legion |
| Microport Orthopedics INC | $139.49 | 2025 | Mpo Medial Pivot Knee |
| Pacira Pharmaceuticals Incorporated | $102.20 | 2023-2025 | Zilretta, Exparel |
| Pacira Therapeutics, INC. | $72.97 | 2019-2020 | |
| Boston Scientific Corporation | $46.16 | 2022 | |
| Bioventus LLC | $23.20 | 2019 | |
| Kci USA, INC. | $16.24 | 2019 | |
| Kinex Medical Company LLC | $13.94 | 2020 | |
| Medtronic USA, INC. | $12.97 | 2019 | |
| Orthofix Medical, INC. | $9.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Calfee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.